Full metadata record
DC FieldValueLanguage
dc.creatorRodriguez-Calvillo, M. (Mercedes)-
dc.creatorInoges, S. (Susana)-
dc.creatorLopez-Diaz-de-Cerio, A. (Ascensión)-
dc.creatorZabalegui, N. (Natalia)-
dc.creatorPanizo, C. (Carlos)-
dc.creatorHernandez, M. (Milagros)-
dc.creatorPerez-Calvo, J. (Javier)-
dc.creatorProsper-Cardoso, F. (Felipe)-
dc.creatorMelero, I. (Ignacio)-
dc.creatorSanchez-Ibarrola, A. (Alfonso)-
dc.creatorRocha, E. (Eduardo)-
dc.creatorBendandi, M. (Maurizio)-
dc.date.accessioned2014-03-10T09:52:49Z-
dc.date.available2014-03-10T09:52:49Z-
dc.date.issued2004-
dc.identifier.citationRodríguez Calvillo M, Inogés S, López Díaz de Cerio A, Zabalegui N, Panizo C, Hernández M, et al. Pasado, presente y futuro de la vacunación anti-idiotipo. Rev Med Univ Navarra. 2004 Jul-Sep;48(3):14-23.es_ES
dc.identifier.issn0556-6177-
dc.identifier.urihttps://hdl.handle.net/10171/35407-
dc.description.abstractCancer vaccines are conceived as therapeutic tools, in contrast to the prophylactic vaccines used to fight against infectious diseases. Among the most potent therapeutic vaccines, anti-idiotype vaccination is directed against the tumor idiotype, the only well-characterized tumor antigen displayed in neoplastic B-cells. Anti-idiotype vaccines have demonstrated clinical benefit against follicular lymphoma and are currently being evaluated in two different phase III clinical trials. Additional emerging strategies, which include the use of dendritic cells and the production of vaccines via molecular means will surely allow us to draw important conclusions concerning the treatment of cancer patients.es_ES
dc.language.isospaes_ES
dc.publisherEdiciones Universidad de Navarraes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectInmunoterapiaes_ES
dc.subjectMieloma múltiplees_ES
dc.subjectVacunaes_ES
dc.subjectIdiotipoes_ES
dc.subjectLinfomaes_ES
dc.titlePasado, presente y futuro de la vacunación anti-idiotipoes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES

Files in This Item:
Thumbnail
File
Rev Med pasado pag 14-23.pdf
Description
Size
322.01 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.